Surface CD24 expression in tumor cells has been linked with alterations in multiple oncogenic signaling pathways, including Src/STAT3 [21], EGFR [22], HER2 [23], Ras-like GTPase [24], MAPK [25,26], AKT/mTOR [27], WNT/β-catenin [28], and miRNA-related pathways [25]. Here, CD24 is linked to neoplasm.